Lexaria Bioscience Corp LEXX

Alternate Symbol(s): LEXXW

Biotechnology

Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company's patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting more effective oral delivery. DehydraTECH has also evidenced an ability to deliver some drugs effectively across the blood brain barrier. It is advancing several research and development (R&D) activities in both preclinical and clinical programs. Its primary research programs are the investigation of optimal formulations of DehydraTECH-enhanced glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) drugs as well as the investigation of cannabidiol (CBD) for the reduction of hypertension leading to a cleared IND application by the United States Food and Drug Administration. It operates a licensed in-house research laboratory and holds an intellectual property portfolio with around 46 patents granted and many patents pending worldwide.

NDAQ:LEXX - Post by User

Lexaria Bioscience Corp

Bullboard Posts

Post by Lanark1170on Jun 09, 2020 12:41pm

283 Views

Post# 31129234

Reverse Split - As few as ONE share for every 30?!!

From my latest Voting Instruction Form:

They want me to approve the following:
"RESOLVED THAT, should the Company seek a Senior Exchange listing, it is hereby authorized and approved to effect a reverse stock split of the common stock by a ratio of not less than 2 current shares for 1 post reverse stock split share and not more than 30 current shares for 1 post reverse stock split share..."

Comments, please?

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season